Jiaxin Du, Jiale Zhang, Chen Yang, Chuanbo Zhang, Wenyu Lu
{"title":"High throughput screening and metabolic engineering of Saccharopolyspora spinosa for spinosad production.","authors":"Jiaxin Du, Jiale Zhang, Chen Yang, Chuanbo Zhang, Wenyu Lu","doi":"10.1007/s10529-025-03617-0","DOIUrl":null,"url":null,"abstract":"<p><p>The macrolide antibiotics spinosad, synthesized by Saccharopolyspora spinosa, is a highly effective, environmentally-friendly insecticide. However, due to poor fermentation performance and difficulties in engineering S. spinosa strains, the production cost of spinosad is still high, which restricts its industrial application. The industrial strains used for antibiotic production primarily originate from mutagenic screening, whereas traditional screening methods are time-consuming and laborious. Here, an in vitro detection method for spinosad was established to accelerate the breeding of mutated strains of S. spinosa. Firstly, a broad substrate promiscuity glycosyltransferase OleD from Streptomyces antibioticus was selected and employed for the detection of pseudoaglycone (PSA), which serves as the precursor compound for spinosad, through the utilization of colorimetric reactions coupled with glycosylation. Subsequently, the in vitro PSA detection system was optimized and applied for S. spinosa high throughput screening. The final selected mutant strain DUA15 was obtained and showed a 0.80-fold and 0.66-fold increase in spinosad and PSA production compared to the original strain, respectively. Furthermore, genetic engineering technology was combined to obtain the engineered strain D15-102, which showed a 2.9-fold increase in spinosad production compared to the original strain.</p>","PeriodicalId":8929,"journal":{"name":"Biotechnology Letters","volume":"47 4","pages":"74"},"PeriodicalIF":2.1000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Letters","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10529-025-03617-0","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The macrolide antibiotics spinosad, synthesized by Saccharopolyspora spinosa, is a highly effective, environmentally-friendly insecticide. However, due to poor fermentation performance and difficulties in engineering S. spinosa strains, the production cost of spinosad is still high, which restricts its industrial application. The industrial strains used for antibiotic production primarily originate from mutagenic screening, whereas traditional screening methods are time-consuming and laborious. Here, an in vitro detection method for spinosad was established to accelerate the breeding of mutated strains of S. spinosa. Firstly, a broad substrate promiscuity glycosyltransferase OleD from Streptomyces antibioticus was selected and employed for the detection of pseudoaglycone (PSA), which serves as the precursor compound for spinosad, through the utilization of colorimetric reactions coupled with glycosylation. Subsequently, the in vitro PSA detection system was optimized and applied for S. spinosa high throughput screening. The final selected mutant strain DUA15 was obtained and showed a 0.80-fold and 0.66-fold increase in spinosad and PSA production compared to the original strain, respectively. Furthermore, genetic engineering technology was combined to obtain the engineered strain D15-102, which showed a 2.9-fold increase in spinosad production compared to the original strain.
期刊介绍:
Biotechnology Letters is the world’s leading rapid-publication primary journal dedicated to biotechnology as a whole – that is to topics relating to actual or potential applications of biological reactions affected by microbial, plant or animal cells and biocatalysts derived from them.
All relevant aspects of molecular biology, genetics and cell biochemistry, of process and reactor design, of pre- and post-treatment steps, and of manufacturing or service operations are therefore included.
Contributions from industrial and academic laboratories are equally welcome. We also welcome contributions covering biotechnological aspects of regenerative medicine and biomaterials and also cancer biotechnology. Criteria for the acceptance of papers relate to our aim of publishing useful and informative results that will be of value to other workers in related fields.
The emphasis is very much on novelty and immediacy in order to justify rapid publication of authors’ results. It should be noted, however, that we do not normally publish papers (but this is not absolute) that deal with unidentified consortia of microorganisms (e.g. as in activated sludge) as these results may not be easily reproducible in other laboratories.
Papers describing the isolation and identification of microorganisms are not regarded as appropriate but such information can be appended as supporting information to a paper. Papers dealing with simple process development are usually considered to lack sufficient novelty or interest to warrant publication.